Neutralizing antibodies against ANGPTL4 or C5a decreased edema formation, inflammatory cell infiltration, and necrosis along with reduction in tissue enzymes and cytokines in AP and SAP animal models. The gene discussed is C5AR1; the disease is alkaline phosphatase measurement.